The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy and predictors of response of nivolumab in treatment-refractory MSI solid tumors: Results of a tumor-agnostic DRUP cohort.
 
Birgit Geurts
No Relationships to Disclose
 
Laurien Joanna Zeverijn
No Relationships to Disclose
 
Thomas W. Battaglia
No Relationships to Disclose
 
Joris van de Haar
No Relationships to Disclose
 
Jade M. van Berge Henegouwen
No Relationships to Disclose
 
Louisa Rose Hoes
No Relationships to Disclose
 
Hanneke van der Wijngaart
No Relationships to Disclose
 
Paul Roepman
No Relationships to Disclose
 
Wendy W.J. de Leng
No Relationships to Disclose
 
Anne M.L. Jansen
No Relationships to Disclose
 
Vincent van der Noort
No Relationships to Disclose
 
Myriam Chalabi
Consulting or Advisory Role - Bristol-Myers Squibb/Celgene (Inst); MSD (Inst); Numab (Inst)
Research Funding - Bristol-Myers Squibb (Inst); MSD (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Roche/Genentech
 
Lot A. Devriese
Consulting or Advisory Role - Incyte (Inst); MSD (Inst)
 
Carla M.L.- Van Herpen
Consulting or Advisory Role - Bayer (Inst); Bristol-Myers Squibb (Inst); Elevar Therapeutics (Inst); Ipsen (Inst); MSD (Inst); Regeneron (Inst)
Research Funding - AstraZeneca; Bristol-Myers Squibb (Mexico); Ipsen; Merck; MSD; Novartis; Sanofi
 
Hans Gelderblom
Research Funding - AmMax Bio (Inst); AmMax Bio (Inst); Daiichi (Inst); Deciphera (Inst); Ipsen (Inst); Novartis (Inst)
 
Henk M.W. Verheul
Consulting or Advisory Role - lava therapeutics (Inst); Philips Healthcare (Inst)
 
Emile E. Voest
Leadership - Mosaic Therapeutics; Sanofi
Stock and Other Ownership Interests - Mosaic Therapeutics; Sanofi
Consulting or Advisory Role - Biogeneration Ventures; InteRNA
Research Funding - astrazeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Clovis Oncology (Inst); Eisai (Inst); GlaxoSmithKline (Inst); Janssen Oncology (Inst); Lilly (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Roche/Genentech (Inst); Sanofi (Inst); Seagen (Inst)